Complications associated with the use of urokinase and recombinant tissue plasminogen activator for catheter-directed peripheral arterial and venous thrombolysis

Journal of Vascular and Interventional Radiology

Volumn 11, Issue 3, 2000, Pages 295-298

  Ouriel, Kenneth ^a   Gray, Bruce ^a   Clair, Daniel G ^a   Olin, Jeffrey ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Thrombolysis; Tissue type plasminogen activator; Urokinase

Indexed keywords

ALTEPLASE; HEPARIN; THROMBOPLASTIN; UROKINASE;

ARTERY THROMBOSIS; ARTICLE; BLEEDING; BLOOD VESSEL OCCLUSION; BRAIN HEMORRHAGE; CLINICAL TRIAL; DOSE RESPONSE; DRUG CHOICE; DRUG SAFETY; FIBRINOLYTIC THERAPY; HEMATOMA; HUMAN; INTENSIVE CARE UNIT; INTRAVASCULAR CATHETER; MAJOR CLINICAL STUDY; MORTALITY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; TREATMENT OUTCOME; VEIN THROMBOSIS;

EID: 0034062754     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1051-0443(07)61420-1     Document Type: Article

References (12)

1. Ouriel K, Veith FJ, Sasahara AA. A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. N Engl J Med 1998; 338:1105-1111.
2. Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity. The STILE trial. Ann Surg 1994; 220:251-266.
3. Mewissen MW, Seabrook GR, Meissner MH, Cynamon J, Labropoulos N, Haughton SH. Catheter-directed thrombolysis for lower extremity deep venous thrombosis: report of a national multicenter registry. Radiology 1999; 211:39-49.
4. Dake MD, Semba CP. Thrombolytic therapy in venous occlusive disease [abstract]. JVIR 1995; 6(suppl):77S.
5. Goldhaber SZ, Buring JE, Lipnick RJ, Hennekens CH. Pooled analyses of randomized trials of streptokinase and heparin in phlebographically documented acute deep venous thrombosis. Am J Med 1984; 76:393-397.
6. Ricotta JJ, Green RM, DeWeese JA. Use and limitations of thrombolytic therapy in the treatment of peripheral arterial ischemia: results of a multi-institutional questionnaire. J Vasc Surg 1987; 6:45-50.
7. Armon MP, Hopkinson BR. Thrombolysis for acute deep vein thrombosis. Br J Surg 1996; 83:580-581.
8. Working Party on Thrombolysis in the Management of Limb Ischemia. Thrombolysis in the management of lower limb peripheral arterial occlusion: a consensus document. Am J Cardiol 1998; 81:207-218.
9. Meyerovitz M, Goldhaber SZ, Reagan K, et al. Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial and graft occlusions: a randomized trial. Radiology 1990; 175:75-78.
10. Goldhaber SZ, Kessler CM, Heit JA, et al. Recombinant tissuetype plasminogen activator versus a novel dosing regimen of urokinase in acute pulmonary embolism: a randomized controlled multicenter trial. J Am Coll Cardiol 1992; 20:24-30.
11. Gurewich V. Pro-urokinase: history, mechanisms of action, and clinical development. In: Loscalzo J, Sasahara AA, eds. New Therapeutic Agents in Thrombosis and Thrombolysis. New York: Marcel and Dekker, 1997; 539-559.
12. Thomas SM, Gaines P. Avoiding the complications of thrombolysis [abstract]. JVIR 1999; 10(suppl): 246.